Yubi Lin

559 total citations
23 papers, 339 citations indexed

About

Yubi Lin is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Orthopedics and Sports Medicine. According to data from OpenAlex, Yubi Lin has authored 23 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 3 papers in Orthopedics and Sports Medicine. Recurrent topics in Yubi Lin's work include Cardiac electrophysiology and arrhythmias (10 papers), Cardiomyopathy and Myosin Studies (7 papers) and Ion channel regulation and function (6 papers). Yubi Lin is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Cardiomyopathy and Myosin Studies (7 papers) and Ion channel regulation and function (6 papers). Yubi Lin collaborates with scholars based in China, Australia and Singapore. Yubi Lin's co-authors include Xiufang Lin, Jianzhong Xian, Jia Chen, J Fan, Jiana Huang, Zhiping Wang, Jing‐Song Ou, Jun Ma, Yin Huang and Xi Zhang and has published in prestigious journals such as The FASEB Journal, Oncotarget and Acta Pharmaceutica Sinica B.

In The Last Decade

Yubi Lin

21 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yubi Lin China 11 230 81 78 44 25 23 339
Daoyuan Si China 11 190 0.8× 74 0.9× 73 0.9× 40 0.9× 35 1.4× 38 355
Mehmet Tokaç Türkiye 11 228 1.0× 52 0.6× 88 1.1× 26 0.6× 26 1.0× 27 350
Marco Spartera Italy 9 283 1.2× 68 0.8× 34 0.4× 27 0.6× 26 1.0× 20 358
Daniél V. Møller Denmark 7 216 0.9× 41 0.5× 81 1.0× 20 0.5× 25 1.0× 14 341
Gloria M. Gager Austria 8 153 0.7× 63 0.8× 48 0.6× 66 1.5× 30 1.2× 14 273
Pio Cialdella Italy 9 128 0.6× 110 1.4× 54 0.7× 23 0.5× 26 1.0× 26 308
Gajen Kanaganayagam United Kingdom 11 261 1.1× 70 0.9× 131 1.7× 15 0.3× 38 1.5× 20 440
Hans Hillege Netherlands 7 224 1.0× 27 0.3× 38 0.5× 42 1.0× 25 1.0× 13 296
Moriatsu Miyagi Japan 9 166 0.7× 72 0.9× 41 0.5× 125 2.8× 19 0.8× 12 382
S. Gary United States 9 276 1.2× 98 1.2× 101 1.3× 25 0.6× 42 1.7× 16 415

Countries citing papers authored by Yubi Lin

Since Specialization
Citations

This map shows the geographic impact of Yubi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubi Lin more than expected).

Fields of papers citing papers by Yubi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yubi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubi Lin. The network helps show where Yubi Lin may publish in the future.

Co-authorship network of co-authors of Yubi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yubi Lin. A scholar is included among the top collaborators of Yubi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yubi Lin. Yubi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lin, Yubi, Yanling Huang, Jianzhong Xian, et al.. (2022). Reactivation of PPARα alleviates myocardial lipid accumulation and cardiac dysfunction by improving fatty acid β-oxidation in Dsg2-deficient arrhythmogenic cardiomyopathy. Acta Pharmaceutica Sinica B. 13(1). 192–203. 16 indexed citations
4.
Yang, Zhe, Jia Chen, Hong Li, & Yubi Lin. (2022). Genotype-Phenotype Associations with Restrictive Cardiomyopathy Induced by Pathogenic Genetic Mutations. Reviews in Cardiovascular Medicine. 23(6). 185–185. 1 indexed citations
5.
Xian, Jianzhong, Jia Chen, Yin Huang, et al.. (2022). SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF ‐2α signaling pathway in arrhythmogenic cardiomyopathy. The FASEB Journal. 36(7). e22410–e22410. 54 indexed citations
6.
Lin, Yubi, Jiana Huang, Z. Zhang, et al.. (2021). Overlap phenotypes of the left ventricular noncompaction and hypertrophic cardiomyopathy with complex arrhythmias and heart failure induced by the novel truncated DSC2 mutation. Orphanet Journal of Rare Diseases. 16(1). 496–496. 10 indexed citations
7.
Zhao, Ting, Yuting Ma, Z. Zhang, et al.. (2021). Young and early‐onset dilated cardiomyopathy with malignant ventricular arrhythmia and sudden cardiac death induced by the heterozygous LDB3, MYH6, and SYNE1 missense mutations. Annals of Noninvasive Electrocardiology. 26(4). e12840–e12840. 14 indexed citations
8.
Lin, Yubi, Yuhui Shen, Jiana Huang, et al.. (2021). Identification of rare heterozygous linkage R965C‐R1309H mutations in the pore‐forming region of SCN5A gene associated with complex arrhythmia. Molecular Genetics & Genomic Medicine. 9(5). e1613–e1613. 7 indexed citations
9.
Huang, Jiana, Wenliang Zhu, Ruiling Feng, et al.. (2021). Indicators and prediction models for the severity of Covid‐19. International Journal of Clinical Practice. 75(10). e14571–e14571. 10 indexed citations
10.
Zhang, Heng, Qingjie Li, Yubi Lin, et al.. (2020). Interleukin-27 decreases ghrelin production through signal transducer and activator of transcription 3—mechanistic target of rapamycin signaling. Acta Pharmaceutica Sinica B. 10(5). 837–849. 9 indexed citations
12.
Lei, Heping, Hongmin Wu, Jiyan Chen, et al.. (2018). Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy. Acta Pharmacologica Sinica. 40(2). 208–215. 28 indexed citations
13.
Lin, Yubi, Jiana Huang, Ting Zhao, et al.. (2018). Compound and heterozygous mutations of DSG2 identified by Whole Exome Sequencing in arrhythmogenic right ventricular cardiomyopathy/dysplasia with ventricular tachycardia. Journal of Electrocardiology. 51(5). 837–843. 8 indexed citations
14.
Lin, Yubi, Zili Liao, Ruiling Feng, et al.. (2017). Whole exome sequencing identified a pathogenic mutation in RYR2 in a Chinese family with unexplained sudden death. Journal of Electrocardiology. 51(2). 309–315. 8 indexed citations
15.
Lin, Yubi, Ruiling Feng, Zhe Xu, et al.. (2017). Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network. Oncotarget. 8(34). 57003–57011. 12 indexed citations
16.
Chen, Jia, Yubi Lin, Wanqun Chen, et al.. (2015). Changes of Virtual Planar QRS and T Vectors Derived from Holter in the Populations with and without Diabetes Mellitus. Annals of Noninvasive Electrocardiology. 21(1). 69–81. 3 indexed citations
17.
Fan, J, Xin Luo, Jun Ma, et al.. (2015). Anticoagulation Regimens During Pregnancy in Patients With Mechanical Heart Valves: A Systematic Review and Meta-analysis. Canadian Journal of Cardiology. 32(10). 1248.e1–1248.e9. 78 indexed citations
18.
Lin, Yubi, et al.. (2013). Mechanism of and Therapeutic Strategy for Atrial Fibrillation Associated with Diabetes Mellitus. The Scientific World JOURNAL. 2013(1). 209428–209428. 24 indexed citations
19.
Dong, Chang, Shulong Zhang, Donghui Yang, et al.. (2010). Effect of Epicardial Fat Pad Ablation on Acute Atrial Electrical Remodeling and Inducibility of Atrial Fibrillation. Circulation Journal. 74(5). 885–894. 22 indexed citations
20.
Lin, Yubi, Yunlong Xia, Lianjun Gao, et al.. (2009). [Chronic outcome of patients with paroxysmal atrial fibrillation post catheter ablation].. PubMed. 37(12). 1101–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026